The missing link? LGMN connects hypoxia and immunosuppression in glioblastoma.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 37992680.
- Also identified by DOI 10.1016/j.xcrm.2023.101293 and PMC identifier 10694751.
- Licence recorded as CC BY-NC-ND.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
In this issue, Pang and colleagues<sup>1</sup> identify the protease legumain as a potential immunotherapy target in glioblastoma that drives tumor-associated macrophages in response to hypoxia.
Medical subject headings
- Glioblastoma